← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $5.1M of United Therapeutics Corporation

Sold$5,075,919
$534.31Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Oct 9Copier in Oct 12
The stock from Mon, Oct 12 open, $553.49
−1.9%
S&P 500, same days
−1.6%

5 of 30 trading days so far, to the Oct 19 close.

Traded Thu, Oct 8. Filed Fri, Oct 9, 4:31 PM ET, after the close. Returns use the Oct 12 open and the Oct 19 close. Not investment advice.